RPID
$2.35-0.15 (-6.00%)
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.
Recent News
Rapid Micro Biosystems Eyes $37M-$41M 2026 Revenue as Growth Direct Day Draws Record Crowd
Rapid Micro Biosystems (NASDAQ:RPID) executives highlighted the company’s effort to modernize microbial quality control in pharmaceutical manufacturing, discussed recent customer engagement activity, and outlined key variables behind its 2026 outlook during a Q&A session hosted by KeyBanc’s Anna
Rapid Micro Biosystems Inc (RPID) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ...
Despite a 37% revenue surge, Rapid Micro Biosystems Inc (RPID) faces margin pressures and increased net loss, while strategic partnerships and system placements show promising growth.
Rapid Micro Biosystems, Inc. Q4 2025 Earnings Call Summary
Moby summary of Rapid Micro Biosystems, Inc.'s Q4 2025 earnings call
Rapid Micro Biosystems Q4 Earnings Call Highlights
Rapid Micro Biosystems (NASDAQ:RPID) reported fourth-quarter and full-year 2025 results highlighting record quarterly revenue, increased system placements, and expanding recurring revenue, while also outlining expectations for revenue growth and gross margin improvement in 2026. Fourth-quarter resu
February 2026's Standout Penny Stocks To Consider
As February begins, the U.S. stock market is off to a strong start, with major indexes like the Dow Jones and S&P 500 posting significant gains. In such a buoyant market environment, investors often look beyond traditional stocks for opportunities that might offer substantial returns at lower entry points. Penny stocks, while an outdated term, still represent an intriguing investment area where smaller or newer companies can provide growth potential when underpinned by solid financials and...